Bonus BioGroup Company Description
Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy.
The company’s products in development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients.
It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is in phase III clinical trial, as well as in preclinical stage for the treatment of other inflammations and tissue damage, including chronic kidney diseases, osteoarthritis, and cytokine release syndrome.
The company was formerly known as Oceana Advanced Industries Ltd. Bonus BioGroup Ltd. was incorporated in 1981 and is based in Haifa, Israel.
| Country | Israel |
| Founded | 1981 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 49 |
| CEO | Shai Meretzki |
Contact Details
Address: Matam Advanced Technology Park Haifa, 3190501 Israel | |
| Phone | 972 7 3206 7100 |
| Website | bonus-bio.com |
Stock Details
| Ticker Symbol | BBIXF |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | ILS |
| ISIN Number | IL0004850116 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Shai Meretzki Ph.D. | Founder, Chief Executive Officer, President and Director |
| Joseph Rauch M.B.A. | Executive Chairman of the Board |
| Meital Enbar | Chief Financial Officer |
| Dr. Dror Ben David Ph.D. | Chief Operations Officer |
| Dr. Tomer Bronshtein Ph.D. | Vice President of Innovation and Corporate Development |
| Dr. Vered Kivity M.B.A., Ph.D. | Head of Regulatory Affairs and Vice President of Clinical Affairs |